These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30464888)

  • 1. Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle.
    Eid BG
    J Microsc Ultrastruct; 2018; 6(4):171-176. PubMed ID: 30464888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cannabinoid Signaling in Cardiovascular Function and Ischemic Injury.
    Rorabaugh BR; Guindon J; Morgan DJ
    J Pharmacol Exp Ther; 2023 Dec; 387(3):265-276. PubMed ID: 37739804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia.
    Puhl SL
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118462. PubMed ID: 30890410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal Cb
    Visvanathar R; Papanikolaou M; Nôga DA; Pádua-Reis M; Tort ABL; Blunder M
    Rev Neurosci; 2022 Jun; 33(4):413-426. PubMed ID: 34717053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular actions of cannabinoids and their generation during shock.
    Wagner JA; Varga K; Kunos G
    J Mol Med (Berl); 1998; 76(12):824-36. PubMed ID: 9846953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.
    Pacher P; Steffens S; Haskó G; Schindler TH; Kunos G
    Nat Rev Cardiol; 2018 Mar; 15(3):151-166. PubMed ID: 28905873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pharmacology of cannabinoids.
    Pacher P; Bátkai S; Kunos G
    Handb Exp Pharmacol; 2005; (168):599-625. PubMed ID: 16596789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids, blood pressure and the human heart.
    Sarzani R
    J Neuroendocrinol; 2008 May; 20 Suppl 1():58-62. PubMed ID: 18426501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid system as a potential target for drug development in the treatment of cardiovascular disease.
    Mendizábal VE; Adler-Graschinsky E
    Curr Vasc Pharmacol; 2003 Oct; 1(3):301-13. PubMed ID: 15320476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids in the Cardiovascular System.
    Ho WSV; Kelly MEM
    Adv Pharmacol; 2017; 80():329-366. PubMed ID: 28826540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors.
    Oz M; Al Kury L; Keun-Hang SY; Mahgoub M; Galadari S
    Eur J Pharmacol; 2014 May; 731():100-5. PubMed ID: 24642359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptors in atherosclerosis.
    Steffens S; Mach F
    Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
    De Luca MA; Fattore L
    Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective.
    Perin P; Mabou Tagne A; Enrico P; Marino F; Cosentino M; Pizzala R; Boselli C
    Front Neurol; 2020; 11():505995. PubMed ID: 33329293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.
    Hiley CR; Ford WR
    Biol Rev Camb Philos Soc; 2004 Feb; 79(1):187-205. PubMed ID: 15005177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
    Mendizábal VE; Adler-Graschinsky E
    Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.